The development of green analytical methodologies is a critical challenge in the field of pharmaceutical analysis. The ternary mixture investigated in this study consists of the antiretroviral drugs Lamivudine (LMV), Tenofovir alafenamide fumarate (TAF), and Dolutegravir (DTG), which are all approved antiretroviral drugs for the treatment of HIV-1 infection. While LMV was approved in 1995, DTG and TAF were more recently approved in 2013 and 2016, respectively, as newer generation HIV medications with improved efficacy and safety profiles compared to earlier antiretroviral drugs. This study presents three eco-friendly approaches for the simultaneous determination of the ternary mixture. Two HPLC methods were applied: an organic-solvent free mixed-micellar HPLC technique was developed as (method A), using a Cyano column (150 × 4.6 mm,5.0 µm) with a mobile phase consisting of 0.03 M Brij-35, 0.09 M sodium dodecyl sulfate, and 0.02 M ammonium acetate in water, adjusted to pH 3.0. Green solvents were applied in (method B), namely, phosphate buffer 25 mM adjusted to pH 3.0 and ethanol (45:55, v/v) using an Inertsil-C18 column (250 × 4.6 mm,5.0 µm,). Peaks were detected at 258 nm, and the retention times for (method A) were 3.10, 3.95 and 5.03 min, and for (method B) were 2.53, 3.63 and 4.86 min for LMV, TAF and DTG, respectively. Additionally, a green thin-layer chromatographic (TLC) method was developed using a water-isopropanol-formic acid mobile phase (65/35/10,v/v/v) and RP-18 silica gel 60 HPTLC-plates. The drugs were successfully resolved, with retardation factor (Rf) values of 0.26, 0.54 and 0.82 for DTG, TAF, and LMV, respectively. The novel methods were validated and applied successfully in marketed dosage forms. Their greenness profiles were assessed using two recent metrics.
Read full abstract